Response to Letter to the Editor

作者: Lisa L. Bayer , Alison B. Edelman , Aaron B. Caughey , Maria I. Rodriguez

DOI: 10.1016/J.CONTRACEPTION.2012.11.014

关键词:

摘要: We thank Raymond et al. for their interest in our recent article on the cost-effectiveness of ulipristal acetate (UPA) versus single-dose levonorgestrel (LNG) emergency contraception (EC). agree that no study has yet demonstrated a meaningful population-level reduction pregnancy rates with LNG EC use even advanced provision. However studies provided response have own significant limitations and none definitely evaluates at population level. Nevertheless safety efficacy prevention individual women is well established. All models assumptions limitations. Our decision tree model based correct timely utilization EC. recognize there are additional confounding factors when used real life. For example decreased among who further acts unprotected intercourse same cycle. In addition possibly UPA appear to body mass index >or=30 kg/m2 . These confounders others present evaluating When comparing will prevent significantly more pregnancies after or inadequately protected intercourse. This translates cost savings level we modeled potential believe over-the-counter status should be pursued as it decrease unintended associated downstream outcomes health care costs. Reduction critical both society. an underutilized option reduce especially UPA. Policy changes barriers likely helpful promoting effective use. await future well-designed can examine these questions (full-text) Copyright © 2013 Elsevier Inc. rights reserved.

参考文章(9)
Omar M. Shaaban, Shaimaa G. Hassen, Sanna A. Nour, Mervat A. Kames, Entsar M. Yones, Emergency contraceptive pills as a backup for lactational amenorrhea method (LAM) of contraception: a randomized controlled trial. Contraception. ,vol. 87, pp. 363- 369 ,(2013) , 10.1016/J.CONTRACEPTION.2012.07.013
Paul Fine, Henri Mathé, Savita Ginde, Vanessa Cullins, Johanna Morfesis, Erin Gainer, Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstetrics & Gynecology. ,vol. 115, pp. 257- 263 ,(2010) , 10.1097/AOG.0B013E3181C8E2AA
Anna F Glasier, Sharon T Cameron, Paul M Fine, Susan JS Logan, William Casale, Jennifer Van Horn, Laszlo Sogor, Diana L Blithe, Bruno Scherrer, Henri Mathe, Amelie Jaspart, Andre Ulmann, Erin Gainer, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis The Lancet. ,vol. 375, pp. 555- 562 ,(2010) , 10.1016/S0140-6736(10)60101-8
Mitchell D. Creinin, William Schlaff, David F. Archer, Livia Wan, Ron Frezieres, Michael Thomas, Michael Rosenberg, James Higgins, Progesterone Receptor Modulator for Emergency Contraception A Randomized Controlled Trial Obstetrics & Gynecology. ,vol. 108, pp. 1089- 1097 ,(2006) , 10.1097/01.AOG.0000239440.02284.45
Anna Glasier, Sharon T. Cameron, Diana Blithe, Bruno Scherrer, Henri Mathe, Delphine Levy, Erin Gainer, Andre Ulmann, Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel Contraception. ,vol. 84, pp. 363- 367 ,(2011) , 10.1016/J.CONTRACEPTION.2011.02.009